1	Angiopoietin/tie-2	Angiopoietin/tie-2	B-NP	NN	B-protein	8	NMOD	0
2	as	as	B-PP	IN	O	1	NMOD	0
3	mediators	mediator	B-NP	NNS	O	2	PMOD	0
4	of	of	B-PP	IN	O	3	NMOD	0
5	angiogenesis	angiogenesis	B-NP	NN	O	4	PMOD	3	angiogenesis
6	:	:	O	:	O	1	P	0
7	a	a	B-NP	DT	O	8	NMOD	0
8	role	role	I-NP	NN	O	0	ROOT	0
9	in	in	B-PP	IN	O	8	NMOD	0
10	congestive	congestive	B-NP	JJ	O	12	NMOD	0
11	heart	heart	I-NP	NN	O	12	NMOD	0
12	failure	failure	I-NP	NN	O	9	PMOD	0
13	?	?	O	.	O	8	P	0

1	Angiogenic	Angiogenic	B-NP	JJ	B-protein	2	NMOD	3	Angiogenic
2	factors	factor	I-NP	NNS	I-protein	19	NMOD	0
3	,	,	O	,	O	2	P	0
4	in	in	B-PP	IN	O	2	NMOD	0
5	particular	particular	B-NP	JJ	O	4	PMOD	0
6	vascular	vascular	I-NP	JJ	B-protein	9	NMOD	0
7	endothelial	endothelial	I-NP	JJ	I-protein	9	NMOD	0
8	growth	growth	I-NP	NN	I-protein	9	NMOD	0
9	factor	factor	I-NP	NN	I-protein	5	NMOD	0
10	(	(	O	(	O	12	DEP	0
11	VEGF	VEGF	B-NP	NN	B-protein	12	DEP	0
12	)	)	O	)	O	9	NMOD	0
13	and	and	O	CC	O	15	NMOD	0
14	the	the	B-NP	DT	O	15	NMOD	0
15	angiopoietins	angiopoietin	I-NP	NNS	B-protein	19	NMOD	0
16	,	,	O	,	O	19	P	0
17	Ang-1	Ang-1	B-NP	NN	B-protein	19	NMOD	0
18	and	and	O	CC	O	19	NMOD	0
19	-2	-2	B-NP	CD	O	21	SUB	0
20	,	,	O	,	O	19	P	0
21	have	have	B-VP	VBP	O	0	ROOT	0
22	recently	recently	I-VP	RB	O	21	VMOD	0
23	generated	generate	I-VP	VBN	O	21	VC	0
24	significant	significant	B-NP	JJ	O	25	NMOD	0
25	interest	interest	I-NP	NN	O	23	OBJ	0
26	,	,	O	,	O	23	P	0
27	especially	especially	B-ADVP	RB	O	28	PMOD	0
28	in	in	B-PP	IN	O	23	VMOD	0
29	oncology	oncology	B-NP	NN	O	28	PMOD	0
30	.	.	O	.	O	21	P	0

1	The	The	B-NP	DT	O	2	NMOD	0
2	process	process	I-NP	NN	O	5	SUB	0
3	of	of	B-PP	IN	O	2	NMOD	0
4	angiogenesis	angiogenesis	B-NP	NN	O	3	PMOD	3	angiogenesis
5	is	be	B-VP	VBZ	O	0	ROOT	0
6	also	also	I-VP	RB	O	5	VMOD	0
7	thought	think	I-VP	VBN	O	5	VC	0
8	to	to	I-VP	TO	O	9	VMOD	0
9	occur	occur	I-VP	VB	O	7	VMOD	0
10	in	in	B-PP	IN	O	9	VMOD	0
11	response	response	B-NP	NN	O	10	PMOD	0
12	to	to	B-PP	TO	O	11	NMOD	0
13	ischaemic	ischaemic	B-NP	JJ	O	14	NMOD	0
14	conditions	condition	I-NP	NNS	O	12	PMOD	0
15	,	,	O	,	O	14	P	0
16	which	which	B-NP	WDT	O	14	NMOD	0
17	lie	lie	B-VP	VBP	O	16	SBAR	0
18	at	at	B-PP	IN	O	17	VMOD	0
19	the	the	B-NP	DT	O	20	NMOD	0
20	core	core	I-NP	NN	O	18	PMOD	0
21	of	of	B-PP	IN	O	20	NMOD	0
22	cardiovascular	cardiovascular	B-NP	JJ	O	24	NMOD	0
23	disease	disease	I-NP	NN	O	24	NMOD	0
24	states	state	I-NP	NNS	O	21	PMOD	0
25	such	such	B-PP	JJ	O	26	PMOD	0
26	as	as	I-PP	IN	O	24	NMOD	0
27	coronary	coronary	B-NP	JJ	O	29	NMOD	0
28	artery	artery	I-NP	NN	O	29	NMOD	0
29	disease	disease	I-NP	NN	O	33	NMOD	0
30	and	and	O	CC	O	33	NMOD	0
31	congestive	congestive	B-NP	JJ	O	33	NMOD	0
32	heart	heart	I-NP	NN	O	33	NMOD	0
33	failure	failure	I-NP	NN	O	26	PMOD	0
34	.	.	O	.	O	5	P	0

1	However	However	B-ADVP	RB	O	5	VMOD	0
2	,	,	O	,	O	5	P	0
3	current	current	B-NP	JJ	O	4	NMOD	0
4	data	datum	I-NP	NNS	O	5	SUB	0
5	do	do	B-VP	VBP	O	0	ROOT	0
6	not	not	I-VP	RB	O	5	VMOD	0
7	conclusively	conclusively	I-VP	RB	O	5	VMOD	0
8	show	show	I-VP	VBP	O	5	VMOD	0
9	evidence	evidence	B-NP	NN	O	8	OBJ	0
10	of	of	B-PP	IN	O	9	NMOD	0
11	angiogenesis	angiogenesis	B-NP	NN	O	10	PMOD	3	angiogenesis
12	per	per	B-ADVP	FW	O	11	NMOD	0
13	se	se	I-ADVP	FW	O	12	AMOD	0
14	in	in	B-PP	IN	O	11	NMOD	0
15	these	these	B-NP	DT	O	16	NMOD	0
16	conditions	condition	I-NP	NNS	O	14	PMOD	0
17	,	,	O	,	O	5	P	0
18	despite	despite	B-PP	IN	O	5	VMOD	0
19	(	(	O	(	O	22	DEP	0
20	for	for	B-PP	IN	O	22	DEP	0
21	example	example	B-NP	NN	O	20	PMOD	0
22	)	)	O	)	O	24	NMOD	0
23	the	the	B-NP	DT	O	24	NMOD	0
24	presence	presence	I-NP	NN	O	18	PMOD	14	presence
25	of	of	B-PP	IN	O	24	NMOD	0
26	high	high	B-NP	JJ	O	27	NMOD	0
27	levels	level	I-NP	NNS	O	25	PMOD	0
28	of	of	B-PP	IN	O	27	NMOD	0
29	VEGF	VEGF	B-NP	NN	B-protein	31	NMOD	0
30	and	and	I-NP	CC	O	31	NMOD	0
31	Ang-2	Ang-2	I-NP	NN	B-protein	28	PMOD	0
32	.	.	O	.	O	5	P	0

1	High	High	B-NP	JJ	O	2	NMOD	0
2	levels	level	I-NP	NNS	O	11	SUB	0
3	of	of	B-PP	IN	O	2	NMOD	0
4	these	these	B-NP	DT	O	6	NMOD	0
5	angiogenic	angiogenic	I-NP	JJ	B-protein	6	NMOD	3	angiogenic
6	factors	factor	I-NP	NNS	I-protein	3	PMOD	0
7	in	in	B-PP	IN	O	2	NMOD	0
8	heart	heart	B-NP	NN	O	9	NMOD	0
9	disease	disease	I-NP	NN	O	7	PMOD	0
10	also	also	B-ADVP	RB	O	11	VMOD	0
11	have	have	B-VP	VBP	O	0	ROOT	0
12	not	not	I-VP	RB	O	11	VMOD	0
13	translated	translate	I-VP	VBN	O	11	VC	0
14	into	into	B-PP	IN	O	13	VMOD	0
15	clinically	clinically	B-NP	RB	O	16	AMOD	0
16	significant	significant	I-NP	JJ	O	19	NMOD	0
17	new	new	I-NP	JJ	O	19	NMOD	0
18	vessel	vessel	I-NP	NN	O	19	NMOD	0
19	formation	formation	I-NP	NN	O	14	PMOD	2	formation
20	,	,	O	,	O	13	P	0
21	as	as	B-PP	IN	O	13	VMOD	0
22	in	in	B-PP	IN	O	21	PMOD	0
23	accelerated	accelerate	B-NP	VBN	O	25	NMOD	17	accelerated
24	cancer	cancer	I-NP	NN	O	25	NMOD	0
25	growth	growth	I-NP	NN	O	28	NMOD	4	growth
26	or	or	O	CC	O	28	NMOD	0
27	proliferative	proliferative	B-NP	JJ	O	28	NMOD	0
28	retinopathy	retinopathy	I-NP	NN	O	22	PMOD	0
29	.	.	O	.	O	11	P	0

1	Indeed	Indeed	B-ADVP	RB	O	4	VMOD	0
2	,	,	O	,	O	4	P	0
3	we	we	B-NP	PRP	O	4	SUB	0
4	would	would	B-VP	MD	O	0	ROOT	0
5	hypothesize	hypothesize	I-VP	VB	O	4	VC	0
6	that	that	B-SBAR	IN	O	5	VMOD	0
7	these	these	B-NP	DT	O	9	NMOD	0
8	angiogenic	angiogenic	I-NP	JJ	O	9	NMOD	3	angiogenic
9	markers	marker	I-NP	NNS	O	15	SUB	0
10	--	--	O	:	O	15	P	0
11	especially	especially	B-ADVP	RB	O	13	NMOD	0
12	the	the	B-NP	DT	O	13	NMOD	0
13	angiopoietins	angiopoietin	I-NP	NNS	O	15	SUB	0
14	--	--	O	:	O	13	P	0
15	do	do	B-VP	VBP	O	6	SBAR	0
16	not	not	I-VP	RB	O	15	VMOD	0
17	necessarily	necessarily	I-VP	RB	O	15	VMOD	0
18	translate	translate	I-VP	VB	O	15	VC	16	translate
19	into	into	B-PP	IN	O	18	VMOD	0
20	new	new	B-NP	JJ	O	22	NMOD	0
21	vessel	vessel	I-NP	NN	O	22	NMOD	0
22	formation	formation	I-NP	NN	O	19	PMOD	2	formation
23	in	in	B-PP	IN	O	22	NMOD	0
24	congestive	congestive	B-NP	JJ	O	26	NMOD	0
25	heart	heart	I-NP	NN	O	26	NMOD	0
26	failure	failure	I-NP	NN	O	23	PMOD	0
27	(	(	O	(	O	29	DEP	0
28	CHF	CHF	B-NP	NN	B-protein	29	DEP	0
29	)	)	O	)	O	26	NMOD	0
30	,	,	O	,	O	15	P	0
31	but	but	O	CC	O	15	VMOD	0
32	may	may	B-VP	MD	O	15	VMOD	0
33	well	well	I-VP	RB	O	32	VMOD	0
34	reflect	reflect	I-VP	VB	O	32	VC	16	reflect
35	disturbances	disturbance	B-NP	NNS	O	34	OBJ	6	disturbances
36	of	of	B-PP	IN	O	35	NMOD	0
37	endothelial	endothelial	B-NP	JJ	O	38	NMOD	0
38	integrity	integrity	I-NP	NN	O	36	PMOD	0
39	in	in	B-PP	IN	O	38	NMOD	0
40	CHF	CHF	B-NP	NN	B-protein	39	PMOD	0
41	.	.	O	.	O	4	P	0

